About Allinky

Our story

Founded in 2009, Allinky Biopharma leads in targeting the “undruggable” with innovative small molecules. We’re dedicated to finding therapies for unmet medical needs, focusing on cancer and inflammation-related diseases.

At the forefront of this bold ambition, there is a highly skilled team and a renowned advisory board of scientists, MDs, and engineers

Our team

Management team

Patricia Gómez, PhD

Patricia Gómez, PhD

Partner & Head of Preclinical Research

More than 15 years of experience in the biotech sector:

  • Computational chemistry
  • Drug design and development
  • Preclinical research and regulatory affairs
Asunción Burguete, PhD

Asunción Burguete, PhD

Head of Business Development

More than 13 years of experience in the biotech sector:

  • Medicinal chemistry
  • Research Funding
  • Business Development
Miguel Vega, MEng, PDD-IESE

Miguel Vega, MEng, PDD-IESE

Partner, S&T Production

More than 25 years of R&D and BD experience in both the public and biotech business sectors (Allinky Biopharma SL, Spanish National Genomic Foundation, UAM, European Commission):

  • Biological Engineering
  • Technology Transfer
  • Innovation Management
Borja Sánchez

Borja Sánchez

Partner & CFO

More than 29 years of experience in Financial Area, 20 as CFO of Savera Group

Board of Advisors

Prof. Dr. Ángel Messeguer

Prof. Dr. Ángel Messeguer

Partner & Scientific Advisor

Full Research Professor at the National Research Council (CSIC) - Barcelona

More than 40 years of experience in Medicinal Chemistry (Former scientific advisor to Menarini, Lipotec and Salvat)

Prof. Dr. Juan Jesús Pérez

Prof. Dr. Juan Jesús Pérez

Partner & Scientific Advisor

Chairman Chemical Engineering. Polytechnic University of Catalonia - Barcelona

More than 30 years of experience in Comp. Chemistry (Former scientific advisor to Ferrer, Menarini and Salvat)

Prof. Dr. Ignacio Torres Alemán

Prof. Dr. Ignacio Torres Alemán

Partner & Scientific Advisor

Full Research Professor at the National Research Council (CSIC) - Madrid

Ikerbasque Research Professor at Ikerbasque Science Foundation

More than 30 years of experience in R&D (Former scientific advisor to Takeda, Roche and Fonterra)

Prof. Dr. Balbino Alarcón

Prof. Dr. Balbino Alarcón

Partner & Scientific Advisor

Full Research Professor at the National Research Council (CSIC) - Madrid

More than 30 years of experience in R&D (Scientific advisor to Artax Biopharma)

Prof. Dr. Juan Gómez-Reino, MD

Prof. Dr. Juan Gómez-Reino, MD

Partner& Scientific Advisor

Professor of Medicine – Universidad de Santiago de Compostela

Former Head of Rheumatology at University Hospital – Santiago de Compostela

More than 40 years of experience in clinical research

Our values

Scientific excellence

We aspire to lead in scientific innovation, embracing advanced technologies and methodologies. Our commitment is to push knowledge boundaries and convert scientific findings into real-world solutions for unmet medical needs.

Patient-centric approach

Patients are our focus. We’re dedicated to improving patient and family lives through innovative therapies that promise better health outcomes. Understanding the relevance of our mission, we ensure safety, effectiveness, and quality in drug development.

Impactful collaborations

Collaboration is key. We actively form partnerships with academics, researchers, healthcare providers, and industry peers. This collaborative network amplifies our capabilities, speeding up discoveries and advancements for patient benefit globally.